other material
confidence high
sentiment neutral
materiality 0.65
CNS Pharmaceuticals raises ~$1.39M in registered direct offering and private placement
CNS Pharmaceuticals, Inc.
- Priced 568,000 common shares plus warrants for 568,000 shares at $2.45 per unit, gross proceeds ~$1.39M.
- Warrants exercisable at $2.32 per share, expire 5 years from issuance; subject to 4.99%/9.99% ownership limitation.
- Offering expected to close June 27, 2024; net proceeds for working capital and general corporate purposes.
- A.G.P./Alliance Global Partners acting as financial advisor with 6.5% fee plus up to $80,000 expense reimbursement.